Business Wire

ChromaTan Receives a $2M Phase IIB NIH Grant to Develop a Fully Integrated Continuous Purification of AAV via BioRMB™ – a Column-Free Steady-State Continuous Elution ...

LOWER GWYNEDD, Pa.--(BUSINESS WIRE)--ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce the award of NIH IIB grant of $2M ...
SpaceNews

H-IIB Launch Service Privatization

Click to share on X (Opens in new window) Click to share on LinkedIn (Opens in new window) Click to share on Facebook (Opens in new window) Click to share on Reddit (Opens in new window) Click to ...
Hosted on MSN

Endeavor doses first subject in Phase IIb trial of ENV-101 for IPF treatment

Endeavor BioMedicines has dosed the first subject in the randomised Phase IIb WHISTLE-PF trial in Australia, assessing the efficacy and safety of ENV-101 (taladegib), an investigational drug for ...
BioWorld

Gan & Lee’s long-acting GLP-1 shows weight loss in phase IIb

Gan & Lee Pharmaceuticals’ long-acting GLP-1 receptor agonist (GLP-1 RA), GZR-18, achieved as much as 17.29% weight loss in a phase IIb trial in obese and overweight Chinese patients. Developed ...